New information about tumours of the salivary glands: WHO classification 2022 Neues zu Tumoren der Speicheldrüsen: WHO-Klassifikation 2022

Ihrler S, Jurmeister P, Haas C, Greber L, Agaimy A (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Die Pathologie Springer

DOI: 10.1007/s00292-023-01194-5

Abstract

The WHO 2022 classification of head and neck tumours contains another slight increase in the number of listed benign and malignant tumour entities of the salivary glands. This includes conceptual changes and alterations in the terminology of some entities. While some new features are regarded as preliminary or provisional, others are strongly disputed (for example the terminology of intraductal carcinoma). The impact of molecular findings, mainly recurrent gene fusions, continues to increase rapidly and some have been included in the definition of certain tumour entities. The significance of molecular findings is, however, still largely restricted to diagnostic aspects. Newly included entities include microsecretory carcinoma (defined by an SS18::MEF2C fusion), sclerosing microcystic adenocarcinoma (similar to skin adnexal tumours of the same name) and mucinous adenocarcinoma (characterized by AKT1 mutations with heterogeneous morphology).

Authors with CRIS profile

Abbas Agaimy Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Involved external institutions

LMU Klinikum DE Germany (DE) Ludwig-Maximilians-Universität (LMU) DE Germany (DE)

How to cite

APA:

Ihrler, S., Jurmeister, P., Haas, C., Greber, L., & Agaimy, A. (2023). New information about tumours of the salivary glands: WHO classification 2022 Neues zu Tumoren der Speicheldrüsen: WHO-Klassifikation 2022. Die Pathologie. https://doi.org/10.1007/s00292-023-01194-5

MLA:

Ihrler, Stephan, et al. "New information about tumours of the salivary glands: WHO classification 2022 Neues zu Tumoren der Speicheldrüsen: WHO-Klassifikation 2022." Die Pathologie (2023).

BibTeX: Download